Glaukos Corporation (GKOS) Tops Q4 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Glaukos Corporation (GKOS) Tops Q4 EPS by 8c

Glaukos Corporation Announces Fourth Quarter and Full Year 2019 Financial Results

February 27, 2020 4:15 PM EST

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the fourth quarter and full year ended December 31, 2019. Key highlights include:

Achieved 22% net sales growth to $65.8 million in the fourth quarter of 2019, compared to $54.1 million in the fourth quarter of 2018. Achieved 31% net sales growth to $237.0 million for the full year 2019, compared to $181.3 million for the full year 2018. Achieved Glaucoma net sales growth... More